Prenetics Global Stock (NASDAQ:PRE)


OwnershipChartTranscripts

Previous Close

$20.56

52W Range

$3.10 - $22.86

50D Avg

$17.84

200D Avg

$12.75

Market Cap

$292.04M

Avg Vol (3M)

$253.88K

Beta

0.36

Div Yield

-

PRE Company Profile


Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

HK

Employees

285

IPO Date

Jul 16, 2021

Website

PRE Performance


Latest Earnings Call Transcripts


Q4 25Feb 23, 26 | 10:00 AM

Peer Comparison


TickerCompany
ATLNAtlantic International Corp.
IMDXInsight Molecular Diagnostics Inc.
STIMNeuronetics, Inc.
OSUROraSure Technologies, Inc.
MXCTMaxCyte, Inc.
SGMOSangamo Therapeutics, Inc.
TLSITriSalus Life Sciences, Inc.
CDXSCodexis, Inc.
PROFProfound Medical Corp.